Lion Point Capital as of Sept. 30, 2024
Portfolio Holdings for Lion Point Capital
Lion Point Capital holds 25 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 40.6 | $18M | 83k | 220.89 | |
| Insmed Com Par $.01 (INSM) | 8.5 | $3.8M | 52k | 73.00 | |
| Geron Corporation (GERN) | 6.4 | $2.9M | 630k | 4.54 | |
| Ardelyx (ARDX) | 5.7 | $2.5M | 370k | 6.89 | |
| Milestone Pharmaceuticals (MIST) | 5.6 | $2.5M | 1.7M | 1.52 | |
| Biohaven (BHVN) | 3.9 | $1.8M | 35k | 49.97 | |
| Mirum Pharmaceuticals Put Option (MIRM) | 3.9 | $1.8M | 45k | 39.00 | |
| Kiniksa Pharmaceuticals Ord Shs Cl A (KNSA) | 3.4 | $1.5M | 61k | 24.99 | |
| Bridgebio Pharma (BBIO) | 2.8 | $1.2M | 49k | 25.46 | |
| Marinus Pharmaceuticals Com New | 2.7 | $1.2M | 694k | 1.76 | |
| Fennec Pharmaceuticals (FENC) | 2.4 | $1.1M | 215k | 5.00 | |
| Mineralys Therapeutics (MLYS) | 2.1 | $957k | 79k | 12.11 | |
| Syndax Pharmaceuticals (SNDX) | 2.0 | $889k | 46k | 19.25 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 1.9 | $839k | 64k | 13.12 | |
| Bluebird Bio | 1.8 | $820k | 1.6M | 0.52 | |
| Regenxbio Inc equity us cm (RGNX) | 1.3 | $606k | 58k | 10.49 | |
| Jasper Therapeutics Com New (JSPR) | 1.3 | $602k | 32k | 18.81 | |
| Disc Medicine (IRON) | 0.8 | $378k | 7.7k | 49.14 | |
| Benitec Biopharma Com New (BNTC) | 0.8 | $358k | 39k | 9.19 | |
| Arcutis Biotherapeutics (ARQT) | 0.7 | $326k | 35k | 9.30 | |
| Seres Therapeutics | 0.7 | $322k | 341k | 0.95 | |
| Lumos Pharma | 0.3 | $153k | 40k | 3.87 | |
| Microsoft Corporation (MSFT) | 0.1 | $43k | 100.00 | 430.30 | |
| Spruce Biosciences (SPRB) | 0.1 | $36k | 75k | 0.47 | |
| Alphabet Cap Stk Cl C (GOOG) | 0.0 | $17k | 100.00 | 167.19 |
